Pinto Coelho, T., Bono, A., Navez, M., & Jouret, F. (25 April 2024). Distribution of Mesenchymal Stromal Cell after intravenous administration in a rat model of multiorgan donation after circulatory death [Paper presentation]. BVN SBN 2024 meeting, Vilvoorde, Belgium. |
Cirillo, A., Résimont, G., Jouret, F., Vidal-Petiot, E., Flamant, M., Delanaye, P., & De Tullio, P. (31 January 2024). How can metabolomics help the follow-up management of kidney transplantation recipients? An untargeted based-metabolomics multiplatform study [Paper presentation]. Metabolomics in Life Science, Umea, Sweden. |
Demuynck, S., Lovinfosse, P., Seidel, L., Jentjens, S., Mekahli, D., Jouret, F., Bammens, B., & Goffin, K. (December 2023). Standardized 4-point scoring scale of [18F]-FDG PET/CT imaging helps in the diagnosis of renal and hepatic cyst infections in patients with autosomal dominant polycystic kidney disease: a validation cohort. Clinical Kidney Journal, 16 (12), 2542 - 2548. doi:10.1093/ckj/sfad159 |
Pinto Coelho, T., ERPICUM, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (December 2023). La mort cérébrale affecte différemment les greffons rénaux par rapport à l’arrêt circulatoire brutal [Paper presentation]. Congrès Annuel Société Francophone de Transplantation, Brest, France. |
Rega, L. R., Janssens, V., Graversen, J. H., Moestrup, S. K., Cairoli, S., Goffredo, B. M., Nevo, N., Courtoy, G. E., Jouret, F., Antignac, C., Emma, F., Pierreux, C. E., & Courtoy, P. J. (12 October 2023). Dietary supplementation of cystinotic mice by lysine inhibits the megalin pathway and decreases kidney cystine content. Scientific Reports, 13 (1), 17276. doi:10.1038/s41598-023-43105-x |
Pinto Coelho, T., Erpicum, P., Navez, M., Chenyu, Z., Detry, O., & Jouret, F. (25 September 2023). LA MORT ENCÉPHALIQUE AFFECTE LES GREFFONS RÉNAUX DE FAÇON DIFFÉRENTE PAR RAPPORT À L’ARRÊT CIRCULATOIRE BRUTAL. Néphrologie et Thérapeutique, 19 (5), 370 - 463. doi:10.1684/ndt.2023.43 |
Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751 * These authors have contributed equally to this work. |
Masson, G., Viva, T., Huart, J., Weekers, L., BONVOISIN, C., Bouquegneau, A., MAWEJA, S., Hamoir, E., Seidel, L., Pottel, H., Lancellotti, P., & Jouret, F. (01 August 2023). The Effect of Elective Ligation of the Arteriovenous Fistula on Cardiac and Renal Functions in Kidney Transplant Recipients. Kidney360, 4 (8), 1130 - 1138. doi:10.34067/KID.0000000000000198 |
Cirillo, A., Vandermeulen, M., Erpicum, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (18 June 2023). Untargeted 1H NMR-based analysis of kidney allograft perfusates identifies a metabolomics signature of delayed graft function [Poster presentation]. Metabolomics Society, Niagara Falls, Canada. |
Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (June 2023). #3687 KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING. Nephrology Dialysis Transplantation, 38 (Supplement 1), 913. doi:10.1093/ndt/gfad063c_3687 |
Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113. |
Huart, J., Persu, A., Lengelé, J.-P., Krzesinski, J.-M., Jouret, F., & Stergiou, G. (2023). Pathophysiology of the Nondipping Blood Pressure Pattern. Hypertension. doi:10.1161/HYPERTENSIONAHA.122.19996 |
Khbouz, B., Gu, S., Pinto Coelho, T., LALLEMAND, F., & Jouret, F. (05 January 2023). Radiotherapy Advances in Renal Disease—Focus on Renal Ischemic Preconditioning. Bioengineering, 10 (1), 68. doi:10.3390/bioengineering10010068 |
Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (2023). KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING [Paper presentation]. ESOT congress 2023, Athens, Greece. |
Résimont, G., VRANKEN, L., Pottel, H., JOURET, F., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (27 June 2022). Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations. Clinical Chemistry and Laboratory Medicine, 60 (7), 1064-1072. doi:10.1515/cclm-2022-0049 |
Cirillo, A., Résimont, G., Delanaye, P., Emmanuelle Vidal-Petiot, Martin Flamant, Jouret, F., & De Tullio, P. (19 June 2022). Application of metabolomics to the evaluation of kidney function and kidney transplantation [Poster presentation]. Metabolomics Society. |
BOUQUEGNEAU, A., MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., CAVALIER, E., & DELANAYE, P. (May 2022). Bone Mineral Density, Bone Micro-Architecture Evolution After Kidney Transplantation: A Prospective Cohort Study. Nephrology Dialysis Transplantation, 37 (Supplement_3). doi:10.1093/ndt/gfac073.006 |
ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344. |
GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337. |
GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211. |
VALDES SOCIN, H. G., SCHEEN, A., JOURET, F., GROSCH, S., & DELANAYE, P. (March 2022). De la découverte de la phlorizine (une histoire belge) aux inhibiteurs des SGLT2. Revue Médicale de Liège, 77 (3), 175-180. |
Dachy, A., Decuypère, J.-P., Vennekens, R., Jouret, F., & mekahli, D. (2022). Is autosomal dominant polycystic kidney disease an early sweet disease? Pediatric Nephrology. doi:10.1007/s00467-021-05406-z |
DELANAYE, P., DUBOIS, B., CAVALIER, E., & JOURET, F. (2022). Vignette diagnostique de l’étudiant : approche diagnostique de la maladie rénale chronique. Revue Médicale de Liège, 7 (4), 249-252. |
VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., JOURET, F., & DETRY, O. (2022). Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats. Frontiers in Immunology, 13, 877953. doi:10.3389/fimmu.2022.877953 |
VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323 |
Firket, L., Descy, J., Seidel, L., Bonvoisin, C., Bouquegneau, A., Grosch, S., Jouret, F., & Weekers, L. (November 2021). Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21 (11), 3806-3807. doi:10.1111/ajt.16726 |
Malisoux, C., KOCH, J.-N., MEURISSE, N., Lagny, M., VANDERMEULEN, M., HONORE, P., JOURET, F., DELANAYE, P., & DETRY, O. (August 2021). Perioperative risk factors of acute kidney injury post liver transplantation: a monocentric retrospective cohort study of 260 patients. Transplant International, 34 (S1 POS315), 312. |
VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., Drion, P., JOURET, F., & DETRY, O. (August 2021). Mesenchymal stromal cells combined with everolimus promote Treg expansion but do not synergize in a rat liver transplant rejection model. Transplant International, 34 (S1 OP519), 101. |
Cirillo, A., Huart, J., Taminiau, B., Descy, J., Saint-Remy, A., Daube, G., KRZESINSKI, J.-M., MELIN, P., JOURET, F., & De Tullio, P. (26 May 2021). Human Stool Metabolome Differs upon 24 h Blood Pressure Levels and Blood Pressure Dipping Status: A Prospective Longitudinal Study [Poster presentation]. CIRM day. |
HUART, J.* , Cirillo, A.* , Taminiau, B., DESCY, J., SAINT-REMY, A., Daube, G., KRZESINSKI, J.-M., MELIN, P., De Tullio, P.* , & JOURET, F.*. (29 April 2021). Human Stool Metabolome Differs upon 24 h Blood Pressure Levels and Blood Pressure Dipping Status: A Prospective Longitudinal Study. Metabolites, 11 (5), 282. doi:10.3390/metabo11050282 * These authors have contributed equally to this work. |
HUART, J.* , Cirillo, A.* , SAINT-REMY, A., KRZESINSKI, J.-M., De Tullio, P.* , & Jouret, F.*. (2021). The faecal abundance of short chain fatty acids is increased in men with a non-dipping blood pressure profile. Acta Cardiologica. doi:10.1080/00015385.2021.1901020 * These authors have contributed equally to this work. |
Detry, O., MEURISSE, N., Jouret, F., BLETARD, N., Delwaide, J., & Moutschen, M. (February 2021). Immunosuppression Withdrawal After Liver Transplantation for Common Variable Immunodeficiency. Liver Transplantation, 27 (3), 456-458. doi:10.1002/lt.25873 |
HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w |
BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1 |
DELANAYE, P., HUART, J., BOUQUEGNEAU, A., & JOURET, F. (2021). Long-term effects of COVID-19 on kidney function [letter to the editor]. The Lancet, 397 (10287), 1807. doi:10.1016/S0140-6736(21)00881-3 |
LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0 |
VALDES SOCIN, H. G., JOURET, F., VROONEN, L., SCHEEN, A., & LANCELLOTTI, P. (2021). Système rénine-angiotensine-aldostérone : bref historique et questionnements face à la pandémie COVID-19. Revue Médicale de Liège, 75, 123-129. |
Vandermeulen, M., ERPICUM, P., POMA, L., Detry, O., & JOURET, F. (11 March 2020). Impact of mesenchymal stromal cells and/or everolimus on T-reg lymphocyte expansion in rats [Paper presentation]. Annual Meeting, Antwerp, Belgium. |
BOVY, C., DELANAYE, P., JOURET, F., & KRZESINSKI, J.-M. (2020). Nouveautés thérapeutiques en Néphrologie : 10 ans d'avancées. Revue Médicale de Liège, 75 (5-6), 336-343. |
ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114. |
HUART, J., KRZESINSKI, J.-M., & JOURET, F. (2020). Argument en faveur d'un rôle du microbiote intestinal dans la physiopathologie de l'hypertension artérielle. Revue Médicale de Liège, 75 (9), 588-592. |
Janssens, P., Jouret, F., Bammens, B., Liebau, M. C., Schaefer, F., Dandurand, A., Perrone, R. D., Muller, R.-U., Pao, C. S., & Mekahli, D. (2020). Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial. Scientific Reports, 10 (1), 4294. doi:10.1038/s41598-020-61303-9 |
Jouret, F., & Devuyst, O. (2020). Targeting chloride transport in autosomal dominant polycystic kidney disease. Cellular Signalling, 73, 109703. doi:10.1016/j.cellsig.2020.109703 |
Neuville, M., Krzesinski, J.-M., & Jouret, F. (2020). Serum levels of carbohydrate antigen 19-9 do not systematically increase in case of liver cyst infection in patients with autosomal dominant polycystic kidney disease [letter to the editor]. Clinical Kidney Journal, 13 (3), 482-483. doi:10.1093/ckj/sfz119 |
PAQUOT, F., WEEKERS, L., BONVOISIN, C., Pottel, H., & Jouret, F. (01 July 2019). "Acute kidney dysfunction with no rejection" is associated with poor renal outcomes at 2 years post kidney transplantation. BMC Nephrology, 20 (1), 249. doi:10.1186/s12882-019-1444-5 |
Andries, A., Daenen, K., Jouret, F., Bammens, B., Mekahli, D., & Van Schepdael, A. (2019). Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression? Pediatric Nephrology. doi:10.1007/s00467-018-4004-5 |
Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., & Bammens, B. (2019). Oxidative stress in chronic kidney disease. Pediatric Nephrology. doi:10.1007/s00467-018-4005-4 |
Rowart, P., Wu, J., Caplan, M. J., & Jouret, F. (2018). Implications of AMPK in the Formation of Epithelial Tight Junctions. International Journal of Molecular Sciences. doi:10.3390/ijms19072040 |
HUART, J., Leenders, J., Taminiau, B., DESCY, J., SAINT-REMY, A., Daube, G., KRZESINSKI, J.-M., MELIN, P., De Tullio, P., & JOURET, F. (18 May 2018). GUT MICROBIOTA AND FAECAL LEVELS OF SHORT CHAIN FATTY ACIDS DIFFER UPON BLOOD PRESSURE LEVELS IN MAN. Nephrology Dialysis Transplantation, 33 (Issue suppl_1), 368–i369. doi:10.1093/ndt/gfy104.SP069 |
Bakker, J., Balthazart, J., Baron, F., Beguin, Y., Bettendorff, L., Blanpain, C., Bureau, F., Caers, J., Cani, P., Cataldo, D., Cornil, C., Clercx, C., Cloots, R., Colige, A., Daube, G., De Backer, O., de Kerchove d'Exaerde, A., Desmecht, D., Desmet, C., ... Wittamer, V. (2018). La souris, le patient, et le faux expert. Décryptage d'une mystification. Le Vif. L'Express. |
ERPICUM, P., Rowart, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2018). What we need to know about lipid-associated injury in case of renal ischemia/reperfusion. American Journal of Physiology. Renal Physiology. doi:10.1152/ajprenal.00322.2018 |
Grieco, G., Janssens, V., Gaide Chevronnay, H. P., N'Kuli, F., Van Der Smissen, P., Wang, T., Shan, J., Vainio, S., Bilanges, B., Jouret, F., Vanhaesebroeck, B., Pierreux, C. E., & Courtoy, P. J. (2018). Vps34/PI3KC3 deletion in kidney proximal tubules impairs apical trafficking and blocks autophagic flux, causing a Fanconi-like syndrome and renal insufficiency. Scientific Reports, 8 (1), 14133. doi:10.1038/s41598-018-32389-z |
HUART, J., Krzesinski, J.-M., & Jouret, F. (2018). Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literature. Clinical Kidney Journal, 11 (4), 586-596. doi:10.1093/ckj/sfy020 |
Meijers, B., Jouret, F., & Evenepoel, P. (2018). Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease. Pharmacological Research, 133, 101-107. doi:10.1016/j.phrs.2018.04.023 |
PAQUOT, F., DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., Evenepoel, P., & CAVALIER, E. (2018). Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients [letter to the editor]. Clinica Chimica Acta, 486, 183-184. doi:10.1016/j.cca.2018.08.003 |
Vanderweckene, P., Weekers, L., Lancellotti, P., & Jouret, F. (2018). Controversies in the management of the haemodialysis-related arteriovenous fistula following kidney transplantation. Clinical Kidney Journal, 11 (3), 406-412. doi:10.1093/ckj/sfx113 |
Yakulov, T. A., Todkar, A. P., Slanchev, K., Wiegel, J., Bona, A., Gross, M., Scholz, A., Hess, I., Wurditsch, A., Grahammer, F., Huber, T. B., Lecaudey, V., Bork, T., Hochrein, J., Boerries, M., Leenders, J., De Tullio, P., Jouret, F., Kramer-Zucker, A., & Walz, G. (2018). CXCL12 and MYC control energy metabolism to support adaptive responses after kidney injury. Nature Communications, 9 (1), 3660. doi:10.1038/s41467-018-06094-4 |
Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., ... Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique. |
ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (September 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and modulates renal lipid metabolism in rats. Transplant International, 30 (S2), 9 (OS004. |
VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051. |
ERPICUM, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (August 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats. Scientific Reports, 7 (1), 8687. doi:10.1038/s41598-017-08726-z |
Rowart, P., ERPICUM, P., KRZESINSKI, J.-M., Sebbagh, M., & JOURET, F. (2017). Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1. Stem Cells International. doi:10.1155/2017/9717353 |
ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & Jouret, F. (16 March 2017). intravenous administration of mesenchymal stream cells modulates renal lipid metabolism in rats [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium. |
WEEKERS, L., ERPICUM, P., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (16 March 2017). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium. |
De Rechter, S., Kringen, J., Janssens, P., Liebau, M. C., Devriendt, K., Levtchenko, E., Bergmann, C., Jouret, F., Bammens, B., Borry, P., Schaefer, F., & Mekahli, D. (2017). Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease. PLoS ONE, 12 (9), 0185779. doi:10.1371/journal.pone.0185779 |
DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., & CAVALIER, E. (2017). Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Scientific Reports, 7 (1), 12623. doi:10.1038/s41598-017-12808-3 |
Erpicum, P., HANSSEN, O., WEEKERS, L., LOVINFOSSE, P., Meunier, P., TSHIBANDA, L., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. NDT Plus, 1-10. doi:10.1093/ckj/sfw077 |
GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc. |
HANSSEN, O., Erpicum, P., LOVINFOSSE, P., Meunier, P., WEEKERS, L., TSHIBANDA, L., Krzesinski, J.-M., HUSTINX, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clinical Kidney Journal, 10 (1), 97-105. doi:10.1093/ckj/sfw062 |
Maillard, N., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). Les pentes d’évolution des CTX, de la phosphatase alkaline osseuse et du P1NP sont associées à celles de la PTH en hémodialyse chronique [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France. |
PIRAPREZ, M., QUINONEZ, K., SEMPELS, M., Waltregny, D., Krzesinski, J.-M., & Jouret, F. (2017). Obstruction urinaire basse : Attention à la levée d'obstacle ! Revue Médicale de Liège, 72 (12), 529-533. |
Sayyed, S. A., JOURET, F., Vermeersch, M., Pérez-Morga, D., & Schurmans, S. (2017). The lipid 5-phoshatase SHIP2 controls renal brush border ultrastructure and function by regulating ERM proteins activation. Kidney International. doi:10.1016/j.kint.2017.01.008 |
Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (18 November 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. American Society of Nephrology | Kidney Week, Chicago, United States. |
Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (27 October 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. MiSOT 2016 - The 6th Expert Meeting on Therapeutic MSCs for Immune Modulation, Regensburg, Germany. |
Jouret, F., Leenders, J., Defraigne, J.-O., Krzesinski, J.-M., & De Tullio, P. (22 September 2016). Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion Injury. PLoS ONE, 11 (9), 1-14. doi:10.1371/journal.pone.0163021 |
NEUVILLE, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (2016). Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease. PLoS ONE. doi:10.1371/journal.pone.0161277 |
Neuville, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (23 May 2016). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease [Poster presentation]. 53 rd congress ERA-EDTA, Vienna, Austria. |
Erpicum, P., WEEKERS, L., DETRY, O., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (28 April 2016). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium. |
Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (28 April 2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients is not Influenced by Renal Function [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium. |
DELANAYE, P., LE GOFF, C., JOURET, F., & CAVALIER, E. (2016). Concordance between Iothalamate and Iohexol Plasma Clearance [letter to the editor]. American Journal of Kidney Diseases, 68 (2), 329-330. doi:10.1053/j.ajkd.2016.01.007 |
Gilissen, J., Jouret, F., Pirotte, B., & Hanson, J. (2016). Insight into SUCNR1 (GPR91) structure and function. Pharmacology and Therapeutics. doi:10.1016/j.pharmthera.2016.01.008 |
Grahammer, F., Ramakrishnan, S. K., Rinschen, M. M., Larionov, A. A., Syed, M., Khatib, H., Roerden, M., Sass, J. O., Helmstaedter, M., Osenberg, D., Kuhne, L., Kretz, O., Wanner, N., Jouret, F., Benzing, T., Artunc, F., Huber, T. B., & Theilig, F. (2016). mTOR Regulates Endocytosis and Nutrient Transport in Proximal Tubular Cells. Journal of the American Society of Nephrology. doi:10.1681/ASN.2015111224 |
JADOUL, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., KRZESINSKI, J.-M., HUSTINX, R., & JOURET, F. (2016). The uptake of 18F-FDG by renal allograft in kidney transplant recipients is not influenced by renal function [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria. |
JOURET, F., CAVALIER, E., & DELANAYE, P. (2016). Concordance between iothalamate and iohexol plasma clearances [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria. |
LOVINFOSSE, P.* , Weekers, L.* , BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & JOURET, F. (2016). Fluorodeoxyglucose F Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. American Journal of Transplantation. doi:10.1111/ajt.13429 * These authors have contributed equally to this work. |
Marx, B., Scuvee, E., Scuvée-Moreau, J., Seutin, V., & Jouret, F. (2016). Mecanismes de l'effet diuretique de la cafeine. MS. Medecine Sciences, 32 (5), 485-90. doi:10.1051/medsci/20163205015 |
WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6. |
ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (November 2015). Impact of timing administration of mesenchymal stromal cells on serum creatinine following renal ischemia/ reperfusion in rats. Transplant International, 28 (S4), 11/O29. |
WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278. |
Neuville, M., Hustinx, R., Krzesinski, J.-M., & Jouret, F. (09 October 2015). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease [Poster presentation]. BENELUX kidney meeting, Eindhoven, Netherlands. |
Erpicum, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (September 2015). Impact du moment d’administration des cellules stromales mésenchymateuses sur la fonction rénale lors d’une ischémie/reperfusion rénale. Néphrologie et Thérapeutique, 11 (5), 257. doi:10.1016/j.nephro.2015.07.002 |
WEEKERS, L., LOVINFOSSE, P., BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (September 2015). Place de la tomographie à émission de positons au 18FDG couplée à la tomodensitométrie en cas de suspicion de rejet aigu du greffon rénal. Néphrologie et Thérapeutique, 11 (5), 280. |
WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3). |
Rowart, P., ERPICUM, P., Defraigne, J.-O., KRZESINSKI, J.-M., & JOURET, F. (24 April 2015). Renal ischemia/reperfusion decreases the expression of DPP-4 [Paper presentation]. BELGIAN SOCIETY OF PHYSIOLOGY AND PHARMACOLOGY, Bruxelles, Belgium. |
Castiglione, V., JOURET, F., Bruyère, O., DUBOIS, B., THOMAS, A., WALTREGNY, D., BEKAERT, A.-C., CAVALIER, E., & GADISSEUR, R. (February 2015). Epidémiologie de la lithiase urinaire sur base d'une analyse morpho-constitutionnelle. Néphrologie et Thérapeutique, 11, 42-49. doi:10.1016/j.nephro.2014.08.003 |
WEEKERS, L., De Tullio, P., BOVY, C., Poma, L., Marée, R., BONVOISIN, C., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (30 January 2015). Activation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury. American Journal of Translational Research, 7 (1), 128-138. |
Dachy, A., Paquot, F., Debray, F.-G., Bovy, C., Christensen, E. I., Collard, L., & Jouret, F. (2015). In-depth phenotyping of a Donnai-Barrow patient helps clarify proximal tubule dysfunction. Pediatric Nephrology, 30 (6), 1027-31. doi:10.1007/s00467-014-3037-7 |
Lagny, M.-G., Jouret, F., Koch, J.-N., Blaffart, F., Donneau, A.-F., Albert, A., ROEDIGER, L., Krzesinski, J.-M., & Defraigne, J.-O. (2015). Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification. BMC Nephrology, 16 (1), 76. doi:10.1186/s12882-015-0066-9 |
Onclinx, C., Dogne, S., Jadin, L., Andris, F., Grandfils, C., Jouret, F., Mullier, F., & Flamion, B. (2015). Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy. Haematologica. doi:10.3324/haematol.2015.123828 |
Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597 |
DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56. |
Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (17 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège [Paper presentation]. Confrontations clinico-biologiques autour de la lithiase urinaire, Paris, France. |
Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (01 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270. |
Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538 |
ERPICUM, P., Krzesinski, J.-M., & Jouret, F. (2014). Place de l'AMP-activated protein kinase dans le preconditionnement ischemique renal. Néphrologie et Thérapeutique. doi:10.1016/j.nephro.2013.10.006 |
JOURET, F., & Krzesinski, J.-M. (2013). Tolvaptan in autosomal dominant polycystic kidney disease [letter to the editor]. New England Journal of Medicine, 368 (13), 1258-9. |
Jouret, F., Wu, J., Hull, M., Rajendran, V., Mayr, B., Schofl, C., Geibel, J., & Caplan, M. J. (2013). Activation of the Ca(2)+-sensing receptor induces deposition of tight junction components to the epithelial cell plasma membrane. Journal of Cell Science, 126 (Pt 22), 5132-42. doi:10.1242/jcs.127555 |
DELANAYE, P., DUBOIS, B., JOURET, F., KRZESINSKI, J.-M., & Moranne, O. (2012). Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? [Poster presentation]. American Society of Nephrology, San Diego, United States - California. |
Ho, T. T., Labriola, L., JOURET, F., Yombi, J. C., Lecouvet, F., Jadoul, M., & Demoulin, N. (2012). Clostridium perfringens hip arthritis in a haemodialysis patient. Acta Clinica Belgica, 67 (1), 49-50. doi:10.2143/ACB.67.1.2062628 |
JOURET, F., Lhommel, R., Devuyst, O., Annet, L., Pirson, Y., Hassoun, Z., & Kanaan, N. (2012). Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrology Dialysis Transplantation, 27 (10), 3746-51. doi:10.1093/ndt/gfs352 |
JOURET, F., Courtoy, P. J., & Devuyst, O. (2011). Segmental and subcellular distribution of CFTR in the kidney. Methods in Molecular Biology, 741, 285-99. doi:10.1007/978-1-61779-117-8_19 |
JOURET, F., Lhommel, R., Beguin, C., Devuyst, O., Pirson, Y., Hassoun, Z., & Kanaan, N. (2011). Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology, 6 (7), 1644-50. doi:10.2215/CJN.06900810 |
Raggi, C., Fujiwara, K., Leal, T., JOURET, F., Devuyst, O., & Terryn, S. (2011). Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease. Pflügers Archiv: European Journal of Physiology, 462 (6), 851-60. doi:10.1007/s00424-011-1026-2 |
Zhang, L., JOURET, F., Rinehart, J., Sfakianos, J., Mellman, I., Lifton, R. P., Young, L. H., & Caplan, M. J. (2011). AMP-activated protein kinase (AMPK) activation and glycogen synthase kinase-3beta (GSK-3beta) inhibition induce Ca2+-independent deposition of tight junction components at the plasma membrane. Journal of Biological Chemistry, 286 (19), 16879-90. doi:10.1074/jbc.M110.186932 |
Ahrabi, A. K., JOURET, F., Marbaix, E., Delporte, C., Horie, S., Mulroy, S., Boulter, C., Sandford, R., & Devuyst, O. (2010). Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion. Nephrology Dialysis Transplantation, 25 (4), 1067-78. doi:10.1093/ndt/gfp611 |
JOURET, F., Castanares-Zapatero, D., & Laterre, P.-F. (2010). Delayed colopericardial fistula and pyopneumopericardium. Intensive Care Medicine, 36 (3), 557-8. doi:10.1007/s00134-009-1701-3 |
JOURET, F., Dupont, M., Jouret-Mourin, A., & Castanares Zapatero, D. (2010). Pneumatosis intestinalis and arcuate ligament. Acta Clinica Belgica, 65 (2), 138-9. doi:10.1179/acb.2010.029 |
JOURET, F., Walrand, S., Parreira, K. S., Courtoy, P. J., Pauwels, S., Devuyst, O., & Jamar, F. (2010). Single photon emission-computed tomography (SPECT) for functional investigation of the proximal tubule in conscious mice. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 298 (2), 454-60. doi:10.1152/ajprenal.00413.2009 |
Reed, A. A. C., Loh, N. Y., Terryn, S., Lippiat, J. D., Partridge, C., Galvanovskis, J., Williams, S. E., JOURET, F., Wu, F. T. F., Courtoy, P. J., Nesbit, M. A., Rorsman, P., Devuyst, O., Ashcroft, F. M., & Thakker, R. V. (2010). CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 298 (2), 365-80. doi:10.1152/ajprenal.00038.2009 |
Senou, M., Khalifa, C., Thimmesch, M., JOURET, F., Devuyst, O., Col, V., Audinot, J.-N., Lipnik, P., Moreno, J. C., Van Sande, J., Dumont, J. E., Many, M.-C., Colin, I. M., & Gerard, A.-C. (2010). A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid. Journal of Clinical Endocrinology and Metabolism, 95 (8), 4021-30. doi:10.1210/jc.2010-0228 |
JOURET, F., & Col, V. (2009). Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma. Acta Clinica Belgica, 64 (5), 457. doi:10.1179/acb.2009.078 |
JOURET, F., & Devuyst, O. (2009). CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflügers Archiv: European Journal of Physiology, 457 (6), 1227-36. doi:10.1007/s00424-008-0594-2 |
Morelle, J., Labriola, L., Lambert, M., Cosyns, J.-P., JOURET, F., & Jadoul, M. (2009). Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction. Clinical Nephrology, 71 (5), 567-70. doi:10.5414/CNP71567 |
Segner, S., JOURET, F., Durant, J.-F., Marot, L., & Kanaan, N. (2009). Cutaneous infection by Alternaria infectoria in a renal transplant patient. Transplant Infectious Disease, 11 (4), 330-2. doi:10.1111/j.1399-3062.2009.00420.x |
Jouret, F., Differding, S., Lhommel, R., Jadoul, M., & Lambert, M. (2008). A mysterious 'homesickness'. NDT Plus, 1 (5), 371-2. doi:10.1093/ndtplus/sfn093 |
JOURET, F., Gailly, P., Martin, D., Debaix, H., Parreira, K. S., Nishita, T., Blanchard, A., Antignac, C., Willnow, T. E., Courtoy, P. J., Scheinman, S. J., Christensen, E. I., & Devuyst, O. (2008). A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction. Kidney International, 74 (1), 52-61. doi:10.1038/sj.ki.5002794 |
JOURET, F., Noirhomme, S., Grandin, C., Lonneux, M., Godfraind, C., Lambert, M., & Lefebvre, C. (2008). Atteinte cerebrale au cours d'une maladie de Wegener. Revue de Médecine Interne, 29 (11), 912-6. doi:10.1016/j.revmed.2008.04.003 |
JOURET, F., & Pirson, Y. (2008). Ingenierie tissulaire du parenchyme renal : une hypothese therapeutique ? MS. Medecine Sciences, 24 (6-7), 561-3. doi:10.1051/medsci/20082467561 |
Lambert, M., JOURET, F., Lonneux, M., & Jamar, F. (2008). Mismatch of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnetate thyroid scan in subacute thyroiditis. Acta Clinica Belgica, 63 (3), 209-10. doi:10.1179/acb.2008.034 |
JOURET, F., Bernard, A., Hermans, C., Dom, G., Terryn, S., Leal, T., Lebecque, P., Cassiman, J.-J., Scholte, B. J., de Jonge, H. R., Courtoy, P. J., & Devuyst, O. (2007). Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney. Journal of the American Society of Nephrology, 18 (3), 707-18. doi:10.1681/ASN.2006030269 |
Terryn, S., JOURET, F., Vandenabeele, F., Smolders, I., Moreels, M., Devuyst, O., Steels, P., & Van Kerkhove, E. (2007). A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology, 293 (2), 476-85. doi:10.1152/ajprenal.00363.2006 |
JOURET, F. (2006). Chloride transporters and vacuolar H+-ATPase in nephrogenesis and congenital tubulopathies [Doctoral thesis, UCL - Université Catholique de Louvain]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/134994 |
Sacre, A., JOURET, F., Manicourt, D., & Devuyst, O. (2006). Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrology Dialysis Transplantation, 21 (10), 2995-6. doi:10.1093/ndt/gfl251 |
van den Hove, M.-F., Croizet-Berger, K., JOURET, F., Guggino, S. E., Guggino, W. B., Devuyst, O., & Courtoy, P. J. (2006). The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. Endocrinology, 147 (3), 1287-96. doi:10.1210/en.2005-1149 |
Devuyst, O., JOURET, F., Auzanneau, C., & Courtoy, P. J. (2005). Chloride channels and endocytosis: new insights from Dent's disease and ClC-5 knockout mice. Nephron. Clinical Practice, 99 (3), 69-73. doi:10.1159/000083210 |
JOURET, F., Auzanneau, C., Debaix, H., Wada, G.-H. S., Pretto, C., Marbaix, E., Karet, F. E., Courtoy, P. J., & Devuyst, O. (2005). Ubiquitous and kidney-specific subunits of vacuolar H+-ATPase are differentially expressed during nephrogenesis. Journal of the American Society of Nephrology, 16 (11), 3235-46. doi:10.1681/ASN.2004110935 |
Smith, A. N., JOURET, F., Bord, S., Borthwick, K. J., Al-Lamki, R. S., Wagner, C. A., Ireland, D. C., Cormier-Daire, V., Frattini, A., Villa, A., Kornak, U., Devuyst, O., & Karet, F. E. (2005). Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone. Journal of the American Society of Nephrology, 16 (5), 1245-56. doi:10.1681/ASN.2004090761 |
JOURET, F., Debaix, H., & Devuyst, O. (2004). A catalog of gene expression in the developing kidney. Kidney International, 66 (2), 867-8. doi:10.1111/j.1523-1755.2004.814_4.x |
JOURET, F., Igarashi, T., Gofflot, F., Wilson, P. D., Karet, F. E., Thakker, R. V., & Devuyst, O. (2004). Comparative ontogeny, processing, and segmental distribution of the renal chloride channel, ClC-5. Kidney International, 65 (1), 198-208. doi:10.1111/j.1523-1755.2004.00360.x |